Cargando…

Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study

BACKGROUND: A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Shams, Rollison, Dana E., Pierce Campbell, Christine M., Waterboer, Tim, Michel, Angelika, Pawlita, Michael, Villa, Luisa L., Lazcano Ponce, Eduardo, Wang, Wei, Borenstein, Amy R., Giuliano, Anna R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125700/
https://www.ncbi.nlm.nih.gov/pubmed/27893841
http://dx.doi.org/10.1371/journal.pone.0167174
_version_ 1782470006435479552
author Rahman, Shams
Rollison, Dana E.
Pierce Campbell, Christine M.
Waterboer, Tim
Michel, Angelika
Pawlita, Michael
Villa, Luisa L.
Lazcano Ponce, Eduardo
Wang, Wei
Borenstein, Amy R.
Giuliano, Anna R.
author_facet Rahman, Shams
Rollison, Dana E.
Pierce Campbell, Christine M.
Waterboer, Tim
Michel, Angelika
Pawlita, Michael
Villa, Luisa L.
Lazcano Ponce, Eduardo
Wang, Wei
Borenstein, Amy R.
Giuliano, Anna R.
author_sort Rahman, Shams
collection PubMed
description BACKGROUND: A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men. OBJECTIVES: To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs. METHODS: A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (β types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), α type 27, γ type 4, μ type 1, and ν type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated. RESULTS: Overall, seropositivity to ≥1 cutaneous HPV type (any-HPV) and ≥1 β types (any-β) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for ɤ-HPV 4, μ-HPV 1, and β-HPV 8. No statistically significant association was observed between any-HPV, any-β, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses. CONCLUSIONS: Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men.
format Online
Article
Text
id pubmed-5125700
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51257002016-12-15 Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study Rahman, Shams Rollison, Dana E. Pierce Campbell, Christine M. Waterboer, Tim Michel, Angelika Pawlita, Michael Villa, Luisa L. Lazcano Ponce, Eduardo Wang, Wei Borenstein, Amy R. Giuliano, Anna R. PLoS One Research Article BACKGROUND: A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men. OBJECTIVES: To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs. METHODS: A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (β types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), α type 27, γ type 4, μ type 1, and ν type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated. RESULTS: Overall, seropositivity to ≥1 cutaneous HPV type (any-HPV) and ≥1 β types (any-β) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for ɤ-HPV 4, μ-HPV 1, and β-HPV 8. No statistically significant association was observed between any-HPV, any-β, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses. CONCLUSIONS: Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men. Public Library of Science 2016-11-28 /pmc/articles/PMC5125700/ /pubmed/27893841 http://dx.doi.org/10.1371/journal.pone.0167174 Text en © 2016 Rahman et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rahman, Shams
Rollison, Dana E.
Pierce Campbell, Christine M.
Waterboer, Tim
Michel, Angelika
Pawlita, Michael
Villa, Luisa L.
Lazcano Ponce, Eduardo
Wang, Wei
Borenstein, Amy R.
Giuliano, Anna R.
Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study
title Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study
title_full Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study
title_fullStr Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study
title_full_unstemmed Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study
title_short Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study
title_sort seroprevalence of cutaneous human papillomaviruses and the risk of external genital lesions in men: a nested case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125700/
https://www.ncbi.nlm.nih.gov/pubmed/27893841
http://dx.doi.org/10.1371/journal.pone.0167174
work_keys_str_mv AT rahmanshams seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT rollisondanae seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT piercecampbellchristinem seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT waterboertim seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT michelangelika seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT pawlitamichael seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT villaluisal seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT lazcanoponceeduardo seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT wangwei seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT borensteinamyr seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy
AT giulianoannar seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy